[1]刘雪莉,贠秀俐.老年2型糖尿病患者发生动脉粥样硬化性心血管疾病的危险因素分析[J].医学信息,2024,37(07):51-56.[doi:10.3969/j.issn.1006-1959.2024.07.009]
　LIU Xue-li,YUN Xiu-li.Analysis of Risk Factors for Atherosclerotic Cardiovascular Disease in Elderly Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2024,37(07):51-56.[doi:10.3969/j.issn.1006-1959.2024.07.009]
点击复制

老年2型糖尿病患者发生动脉粥样硬化性心血管疾病的危险因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年07期
页码:
51-56
栏目:
公共卫生信息学
出版日期:
2024-04-01

文章信息/Info

Title:
Analysis of Risk Factors for Atherosclerotic Cardiovascular Disease in Elderly Patients with Type 2 Diabetes Mellitus
文章编号:
1006-1959（2024）07-0051-06
作者:
刘雪莉; 贠秀俐
（1.延安大学医学院，陕西 延安 716000；2.延安大学附属医院护理部，陕西 延安 716099）
Author(s):
LIU Xue-li; YUN Xiu-li
(1.School of Medicine,Yan ’an University,Yan’ an 716000,Shaanxi,China;2.Department of Nursing,the Affiliated Hospital of Yan’an University,Yan ’an 716099,Shaanxi,China)
关键词:
2型糖尿病; 动脉粥样硬化性心血管疾病; 老年护理
Keywords:
Type 2 diabetes mellitus; Atherosclerotic cardiovascular disease; Elderly care
分类号:
R473.5
DOI:
10.3969/j.issn.1006-1959.2024.07.009
文献标志码:
A
摘要:
目的 探讨老年2型糖尿病患者（T2DM）合并动脉粥样硬化性心血管疾病（ASCVD）的现状，并分析其危险因素。方法 采用方便抽样法，选取2022年7月-11月在延安大学附属医院内分泌代谢科住院的老年2型糖尿病患者作为调查对象，收集患者一般资料及疾病相关资料。按照患者是否合并ASCVD将其分为ASCVD组和无ASCVD组，进行单因素分析；并以患者是否发生ASCVD为因变量，将单因素分析中有统计学意义的变量纳入二元Logistic回归分析其独立危险因素。结果 本研究共纳入219例老年2型糖尿病患者，发生ASCVD的患者有77例，发生率为35.16%，主要是冠心病与缺血性脑卒中。单因素分析显示，男性、吸烟或病程长的患者更易发生ASCVD，且女性发生ASCVD是男性的0.459倍，而动脉血管硬化等级（3~4级、5~6级）、合并周围血管病变、胆固醇（TC）3个变量进入二元Logistic回归方程（OR=2.430、11.194、3.059、0.459，P＜0.05），且其是老年2型糖尿病患者发生ASCVD的独立危险因素。结论 老年2型糖尿病患者ASCVD发生率较高，特别是男性、吸烟、病程长的患者，应定期检查、评估患者动脉血管硬化等级[踝肱动脉指数（ABI）、肱踝动脉脉搏波传导速度（baPWV）]、胆固醇等指标，并在生活方式及药物治疗依存性上给予相应健康指导，以延缓动脉硬化，降低患者ASCVD的发生率。
Abstract:
Objective To investigate the prevalence and risk factors of atherosclerotic cardiovascular disease (ASCVD) in elderly patients with type 2 diabetes mellitus (T2DM).Methods A convenient sampling method was used to select elderly patients with type 2 diabetes mellitus who were hospitalized in the Department of Endocrinology and Metabolism of the Affiliated Hospital of Yan’an University from July to November 2022 as the subjects of investigation. The general data and disease-related data of the patients were collected. According to whether the patients were combined with ASCVD, they were divided into ASCVD group and non-ASCVD group for univariate analysis. Taking the occurrence of ASCVD in patients as the dependent variable, the statistically significant variables in the univariate analysis were included in the binary Logistic regression analysis to analyze the independent risk factors.Results A total of 219 elderly patients with type 2 diabetes mellituswere included in this study. There were 77 patients with ASCVD, with an incidence of 35.16%, mainly coronary heart disease and ischemic stroke. Univariate analysis showed that patients were male, and with smoking or long course of disease were more likely to develop ASCVD, and the incidence of ASCVD in women was 0.459 times higher than that in men. The three variables of arterial sclerosis grade (grade 3-4, grade 5-6), peripheral vascular disease and cholesterol (TC) entered the binary logistic regression equation (OR=2.430, 11.194, 3.059, 0.459, P<0.05), which were independent risk factors for ASCVD in elderly patients with type 2 diabetes mellitus.Conclusion The incidence of ASCVD in elderly patients with type 2 diabetes mellitusis high, especially in patients were male, and with male, smoking and long course of disease. Regular examination and evaluation of patients with arterial vascular sclerosis grade [ankle brachial artery index (ABI), brachial ankle pulse wave velocity (baPWV)], cholesterol and other indicators, and in the lifestyle and drug treatment dependence to give the corresponding health guidance, in order to delay atherosclerosis, reduce the incidence of ASCVD in patients.

参考文献/References:

[1]Sun H,Saeedi P,Karuranga S,et al.IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022,183:109119.[2]国家统计局,国务院第七次全国人口普查领导小组办公室.第七次全国人口普查公报(第五号)——人口年龄构成情况[J].中国统计,2021,5:10-11.[3]Cole JB,Florez JC.Genetics of diabetes mellitus and diabetes complications[J].Nat Rev Nephrol,2020,16(7):377-390.[4]Low Wang CC,Hess CN,Hiatt WR,et al.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations[J].Circulation,2016,133(24):2459-502.[5]蒲丹岚,尹经霞,唐萍,等.2型糖尿病患者动脉粥样硬化性心血管疾病风险横断面研究[J].重庆医科大学学报,2016,41(11):1131-1136.[6]中国医师协会内分泌代谢科医师分会.2型糖尿病早期大血管病变无创性检查的专家共识[J].中国循环杂志,2014,29(3):167-171.[7]崔敏,彭彦平,高杰清,等.血清维生素D水平预测2型糖尿病患者大血管和微血管并发症的临床意义[J].解放军预防医学杂志,2019,37(2):175-176,179.[8]张蕊,秦诗阳,何建秋,等.脂联素、直接胆红素及甘油三酯对2型糖尿病患者大血管病变的诊断价值[J].中国现代医学杂志,2023,33(1):13-18.[9]周谢达,陈妍,肖黄梦,等.糖尿病住院患者颈动脉及下肢动脉血管斑块危险因素分析[J].岭南心血管病杂志,2017,23(3):308-313,361.[10]Herman WH,Ye W,Griffin SJ,et al.Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)[J].Diabetes Care,2015,38(8):1449-1455.[11]《中国老年型糖尿病防治临床指南》编写组.中国老年2型糖尿病防治临床指南(2022年版)[J].中国糖尿病杂志,2022,30(1):2-51.[12]洪天配,母义明,纪立农,等.2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识[J].中国糖尿病杂志,2017,25(6):481-492.[13]涂静,袁刚.糖尿病周围血管病变的患病率及危险因素分析[J].临床内科杂志,2014,31(1):52-54.[14]杜芳,王学红,张莉,等.老年住院患者皮肤干燥症现况调查及相关影响因素分析[J].中国实用护理杂志,2022,38(34):2684-2690.[15]Salami JA,Valero-Elizondo J,Ogunmoroti O,et al.Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures PanelSurvey[J].J Am Heart Assoc,2017,6(6):e004996.[16]黄秋菊,吴军,林双,等.2型糖尿病合并大血管病变患者营养不良风险现状及影响因素研究[J].河北医学,2022,28(9):1502-1506.[17]Paneni F,Beckman JA,Creager MA,etal.Diabetes and vascular disease: pathophysiology,clinical consequences, and medical therapy: part II[J].Eur Heart J,2013,34(31):2444-2452.[18]张雨薇,周广举,童南伟.中国成人糖尿病患者动脉粥样硬化脑心血管疾病分级预防指南解读[J].中国实用内科杂志,2016,36(6):453-457.[19]GBD 2016 Causes of Death Collaborators.Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1151-1210.[20]马萍,韩笑,王广勇,等.老年冠心病合并糖尿病患者血清Apelin-13水平及与Gensini评分的关系[J].中国老年学杂志,2022,42(3):516-519.[21]Yu ZH,Wang HT,Tu C.Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease[J].Eur J Med Res,2017,22(1):2.[22]Shimabukuro M.SIRT1 and Gender Differences in Atherosclerotic Cardiovascular Disease[J].J Atheroscler Thromb,2020,27(1):8-10.[23]Lin CC,Li CI,Liu CS,et al.Prediction of all-cause and cardiovascular mortality using ankle-brachial index andbrachial-ankle pulsewave velocity in patients with type 2 diabetes[J].Sci Rep,2022,12(1):11053.[24]唐世凡,王朝晖,程锡华,等.2型糖尿病患者大血管病变与踝臂脉搏波传导速度的相关性研究[J].中国糖尿病杂志,2017,25(3):204-207.[25]徐杰,李伟,杨辉.脂代谢紊乱对2型糖尿病患者心血管疾病发生和病死率的影响[J].岭南心血管病杂志,2017,23(6):759-763.[26]张舫,童南伟.2型糖尿病心血管风险评估与防治心血管病的降糖药物选择——《2019ESC/EASD糖尿病、糖尿病前期和心血管疾病指南》解读[J].中国临床医生杂志,2021,49(2):142-148.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(07):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(07):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(07):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(07):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(07):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
　DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(07):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的 疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
　LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(07):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
　BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(07):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]

更新日期/Last Update: 1900-01-01